Citation Impact
Citing Papers
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
Unique carbohydrate–carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose
2011
Global impact of protein arginine phosphorylation on the physiology of Bacillus subtilis
2012
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
Optimal Dissociation Methods Differ for N - and O -Glycopeptides
2020 StandoutNobel
Deciphering O -glycoprotease substrate preferences with O-Pair Search
2022 StandoutNobel
Regulation of CtsR Activity in Low GC, Gram+ Bacteria
2010
Proteomic Analysis of Host Cell Protein Dynamics in the Culture Supernatants of Antibody-Producing CHO Cells
2017
De novo design of modular and tunable protein biosensors
2021 StandoutNatureNobel
Peak Filtering, Peak Annotation, and Wildcard Search for Glycoproteomics
2020
Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice
2020 StandoutNobel
Human antibodies targeting Zika virus NS1 provide protection against disease in a mouse model
2018
Quantitative Phosphoproteomics Reveals the Role of Protein Arginine Phosphorylation in the Bacterial Stress Response
2013
The re-emergence of natural products for drug discovery in the genomics era
2015 Standout
Mechanisms of SARS-CoV-2 entry into cells
2021 Standout
Roles of adaptor proteins in regulation of bacterial proteolysis
2013
Regulatory Cohesion of Cell Cycle and Cell Differentiation through Interlinked Phosphorylation and Second Messenger Networks
2011
Insights into the CLP/HSP100 Chaperone System from Chloroplasts of Arabidopsis thaliana
2011
ClpP: A distinctive family of cylindrical energy‐dependent serine proteases
2007
Protein rescue from aggregates by powerful molecular chaperone machines
2013
Cellular strategies for controlling protein aggregation
2010
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Structure of the Type VI Secretion System Contractile Sheath
2015 StandoutNobel
Cutting-edge mass spectrometry methods for the multi-level structural characterization of antibody-drug conjugates
2015
O-Pair Search with MetaMorpheus for O-glycopeptide characterization
2020 StandoutNobel
A tightly regulated molecular toggle controls AAA+ disaggregase
2012
The Heat Shock Response: Life on the Verge of Death
2010 Standout
The Science of Antibiotic Discovery
2020 Standout
Biological roles of glycans
2016 Standout
Structural Basis for Recognizing Phosphoarginine and Evolving Residue-Specific Protein Phosphatases in Gram-Positive Bacteria
2013 StandoutNobel
Sculpting the Proteome with AAA+ Proteases and Disassembly Machines
2004
Chaperone-protease systems in regulation and protein quality control in Bacillus subtilis
2009
Arginine phosphorylation marks proteins for degradation by a Clp protease
2016 Nature
Insights from native mass spectrometry and ion mobility-mass spectrometry for antibody and antibody-based product characterization
2016
Fc glycans of therapeutic antibodies as critical quality attributes
2015
Selective adaptor dependent protein degradation in bacteria
2017
Protein disaggregation by the AAA+ chaperone ClpB involves partial threading of looped polypeptide segments
2008
Measuring the multifaceted roles of mucin-domain glycoproteins in cancer
2022 StandoutNobel
Recombinant protein expression in Escherichia coli: advances and challenges
2014 Standout
CtsR, the Gram‐positive master regulator of protein quality control, feels the heat
2010
Structural Basis of Mycobacterial Inhibition by Cyclomarin A
2013
Factors Affecting the FcRn-Mediated Transplacental Transfer of Antibodies and Implications for Vaccination in Pregnancy
2017
Molecular Basis for the Unique Role of the AAA+ Chaperone ClpV in Type VI Protein Secretion
2011
Targeting FcRn to Generate Antibody-Based Therapeutics
2018
Structure and mechanism of the hexameric MecA–ClpC molecular machine
2011 Nature
Localization of general and regulatory proteolysis in Bacillus subtilis cells
2008
A tyrosine kinase and its activator control the activity of the CtsR heat shock repressor in B. subtilis
2005
8thAnnual European Antibody Congress 2012
2013
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Glycotherapy: New Advances Inspire a Reemergence of Glycans in Medicine
2013 StandoutNobel
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Challenges of glycosylation analysis and control: an integrated approach to producing optimal and consistent therapeutic drugs
2016
IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8+ T cells to overcome immunotherapy resistance in cancer
2022
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy
2015
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
The tyrosine kinase McsB is a regulated adaptor protein for ClpCP
2007
The elusive middle domain of Hsp104 and ClpB: Location and function
2011
A New Tyrosine Phosphorylation Mechanism Involved in Signal Transduction in <i>Bacillus subtilis</i>
2005
Integrating Protein Homeostasis Strategies in Prokaryotes
2010
Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-Life
2019
Transfer of maternal immunity and programming of the newborn immune system
2017
A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics
2020 StandoutNobel
Adapting the machine: adaptor proteins for Hsp100/Clp and AAA+ proteases
2009
Role of Hsp100/Clp Protease Complexes in Controlling the Regulation of Motility in Bacillus subtilis
2016
Repurposing Hsp104 to Antagonize Seminal Amyloid and Counter HIV Infection
2015 StandoutNobel
The bacterial N-end rule pathway: expect the unexpected
2010
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Functional Diversity of AAA+ Protease Complexes in Bacillus subtilis
2017 StandoutNobel
Strong coupling between surface plasmon polaritons and emitters: a review
2014 Standout
Exploring the diversity of protein modifications: special bacterial phosphorylation systems
2016
Bispecific antibodies: a mechanistic review of the pipeline
2019
Isotype and glycoform selection for antibody therapeutics
2012
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Remodelling of VipA/VipB tubules by ClpV‐mediated threading is crucial for type VI protein secretion
2009
The amyloid state and its association with protein misfolding diseases
2014 Standout
Degradation from the outside in: Targeting extracellular and membrane proteins for degradation through the endolysosomal pathway
2021 StandoutNobel
IgG Subclasses and Allotypes: From Structure to Effector Functions
2014 Standout
Dysregulation of bacterial proteolytic machinery by a new class of antibiotics
2005
Targeting key angiogenic pathways with a bispecific Cross MA b optimized for neovascular eye diseases
2016
Glycoproteomics
2022 StandoutNobel
Characterization of Therapeutic Antibodies and Related Products
2012
Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants
2021
2013
McsB Is a Protein Arginine Kinase That Phosphorylates and Inhibits the Heat-Shock Regulator CtsR
2009 StandoutScienceNobel
Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity
2018
Impact of host cell line choice on glycan profile
2017
Antibiotics and Bacterial Resistance in the 21st Century
2014 Standout
Synthetic Glycobiology: Parts, Systems, and Applications
2020
Conformational control of the bacterial Clp protease by natural product antibiotics
2017
AAA+ Proteases: ATP-Fueled Machines of Protein Destruction
2011
Modulating IgG effector function by Fc glycan engineering
2017
Electron-Based Dissociation Is Needed for O-Glycopeptides Derived from OpeRATOR Proteolysis
2020 StandoutNobel
Requirement of the Zinc-Binding Domain of ClpX for Spx Proteolysis inBacillus subtilisand Effects of Disulfide Stress on ClpXP Activity
2007
Vaccine innovations for emerging infectious diseases—a symposium report
2019 StandoutNobel
Involvement ofBacillus subtilisClpE in CtsR Degradation and Protein Quality Control
2006
Glycoengineered antibodies: towards the next-generation of immunotherapeutics
2018
Adaptor bypass mutations of B acillus subtilis spx suggest a mechanism for YjbH ‐enhanced proteolysis of the regulator Spx by ClpXP
2014
Cyclic di-GMP: the First 25 Years of a Universal Bacterial Second Messenger
2013 Standout
The Role of Electron Transfer Dissociation in Modern Proteomics
2017
Liquid-Liquid Phase Separation in Biology
2014 Standout
Modular repeat protein sculpting using rigid helical junctions
2020 StandoutNobel
YjbH-Enhanced Proteolysis of Spx by ClpXP in Bacillus subtilis Is Inhibited by the Small Protein YirB (YuzO)
2011
Activity Control of the ClpC Adaptor McsB in Bacillus subtilis
2011
The role of thiol oxidative stress response in heat‐induced protein aggregate formation during thermotolerance in B acillus subtilis
2014
Tutorial on Monoclonal Antibody Pharmacokinetics and Its Considerations in Early Development
2018
Survey of the 2009 commercial optical biosensor literature
2011
The ClpP Peptidase Is the Major Determinant of Bulk Protein Turnover in Bacillus subtilis
2004
The antibiotic ADEP reprogrammes ClpP, switching it from a regulated to an uncontrolled protease
2009
Unique double-ring structure of the peroxisomal Pex1/Pex6 ATPase complex revealed by cryo-electron microscopy
2015 StandoutNobel
Head-to-tail interactions of the coiled-coil domains regulate ClpB activity and cooperation with Hsp70 in protein disaggregation
2014
In vivo imaging reveals a tumor-associated macrophage–mediated resistance pathway in anti–PD-1 therapy
2017
Adaptor-mediated Lon proteolysis restrictsBacillus subtilishyperflagellation
2014
Works of Tilman Schlothauer being referenced
MecA, an adaptor protein necessary for ClpC chaperone activity
2003
A Two-pronged Binding Mechanism of IgG to the Neonatal Fc Receptor Controls Complex Stability and IgG Serum Half-life
2017
Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants
2015
Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions
2016
Identification of Potential Sites for Tryptophan Oxidation in Recombinant Antibodies Using tert-Butylhydroperoxide and Quantitative LC-MS
2011
Investigating the Interaction between the Neonatal Fc Receptor and Monoclonal Antibody Variants by Hydrogen/Deuterium Exchange Mass Spectrometry
2014
In Vitro Glycoengineering of IgG1 and Its Effect on Fc Receptor Binding and ADCC Activity
2015
Functional assessment of antibody oxidation by native mass spectrometry
2015
CD4-anchoring HIV-1 Fusion Inhibitor with Enhanced Potency and in Vivo Stability
2008
A human endothelial cell-based recycling assay for screening of FcRn targeted molecules
2018
Adaptor protein controlled oligomerization activates the AAA+ protein ClpC
2006
Simultaneous Assessment of Asp Isomerization and Asn Deamidation in Recombinant Antibodies by LC-MS following Incubation at Elevated Temperatures
2012
Analytical FcRn affinity chromatography for functional characterization of monoclonal antibodies
2013
Cell Type-Specific and Site Directed N-Glycosylation Pattern of FcγRIIIa
2011